KINASE MODULATORS
The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides oxindole derivatives which inhibit, regul...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | CHENG, WEI LE, DONNA, T PARKS, JASON JEVIOUS WEN,, ZHAOYANG MAC, MORRISON, B BROWN, S., DAVID KIM, MOON, HWAN XU, WEI CO, ERICK WANG NUSS, JOHN, M LEW, AMY BANNEN, LYNNE, CANNE KLEIN, RHETT RONALD |
description | The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides oxindole derivatives which inhibit, regulate and/or modulate kinase receptor, particularly VEGF receptor 2 (Flk-1/KDR), FGFR1, and PDGFR (alpha and beta), signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1581309A4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1581309A4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1581309A43</originalsourceid><addsrcrecordid>eNrjZBD09vRzDHZV8PV3CfVxDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAYamFobGBpaOJsZEKAEA8OAdgQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>KINASE MODULATORS</title><source>esp@cenet</source><creator>CHENG, WEI ; LE, DONNA, T ; PARKS, JASON JEVIOUS ; WEN,, ZHAOYANG ; MAC, MORRISON, B ; BROWN, S., DAVID ; KIM, MOON, HWAN ; XU, WEI ; CO, ERICK WANG ; NUSS, JOHN, M ; LEW, AMY ; BANNEN, LYNNE, CANNE ; KLEIN, RHETT RONALD</creator><creatorcontrib>CHENG, WEI ; LE, DONNA, T ; PARKS, JASON JEVIOUS ; WEN,, ZHAOYANG ; MAC, MORRISON, B ; BROWN, S., DAVID ; KIM, MOON, HWAN ; XU, WEI ; CO, ERICK WANG ; NUSS, JOHN, M ; LEW, AMY ; BANNEN, LYNNE, CANNE ; KLEIN, RHETT RONALD</creatorcontrib><description>The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides oxindole derivatives which inhibit, regulate and/or modulate kinase receptor, particularly VEGF receptor 2 (Flk-1/KDR), FGFR1, and PDGFR (alpha and beta), signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions.</description><edition>7</edition><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090729&DB=EPODOC&CC=EP&NR=1581309A4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090729&DB=EPODOC&CC=EP&NR=1581309A4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHENG, WEI</creatorcontrib><creatorcontrib>LE, DONNA, T</creatorcontrib><creatorcontrib>PARKS, JASON JEVIOUS</creatorcontrib><creatorcontrib>WEN,, ZHAOYANG</creatorcontrib><creatorcontrib>MAC, MORRISON, B</creatorcontrib><creatorcontrib>BROWN, S., DAVID</creatorcontrib><creatorcontrib>KIM, MOON, HWAN</creatorcontrib><creatorcontrib>XU, WEI</creatorcontrib><creatorcontrib>CO, ERICK WANG</creatorcontrib><creatorcontrib>NUSS, JOHN, M</creatorcontrib><creatorcontrib>LEW, AMY</creatorcontrib><creatorcontrib>BANNEN, LYNNE, CANNE</creatorcontrib><creatorcontrib>KLEIN, RHETT RONALD</creatorcontrib><title>KINASE MODULATORS</title><description>The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides oxindole derivatives which inhibit, regulate and/or modulate kinase receptor, particularly VEGF receptor 2 (Flk-1/KDR), FGFR1, and PDGFR (alpha and beta), signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBD09vRzDHZV8PV3CfVxDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAYamFobGBpaOJsZEKAEA8OAdgQ</recordid><startdate>20090729</startdate><enddate>20090729</enddate><creator>CHENG, WEI</creator><creator>LE, DONNA, T</creator><creator>PARKS, JASON JEVIOUS</creator><creator>WEN,, ZHAOYANG</creator><creator>MAC, MORRISON, B</creator><creator>BROWN, S., DAVID</creator><creator>KIM, MOON, HWAN</creator><creator>XU, WEI</creator><creator>CO, ERICK WANG</creator><creator>NUSS, JOHN, M</creator><creator>LEW, AMY</creator><creator>BANNEN, LYNNE, CANNE</creator><creator>KLEIN, RHETT RONALD</creator><scope>EVB</scope></search><sort><creationdate>20090729</creationdate><title>KINASE MODULATORS</title><author>CHENG, WEI ; LE, DONNA, T ; PARKS, JASON JEVIOUS ; WEN,, ZHAOYANG ; MAC, MORRISON, B ; BROWN, S., DAVID ; KIM, MOON, HWAN ; XU, WEI ; CO, ERICK WANG ; NUSS, JOHN, M ; LEW, AMY ; BANNEN, LYNNE, CANNE ; KLEIN, RHETT RONALD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1581309A43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHENG, WEI</creatorcontrib><creatorcontrib>LE, DONNA, T</creatorcontrib><creatorcontrib>PARKS, JASON JEVIOUS</creatorcontrib><creatorcontrib>WEN,, ZHAOYANG</creatorcontrib><creatorcontrib>MAC, MORRISON, B</creatorcontrib><creatorcontrib>BROWN, S., DAVID</creatorcontrib><creatorcontrib>KIM, MOON, HWAN</creatorcontrib><creatorcontrib>XU, WEI</creatorcontrib><creatorcontrib>CO, ERICK WANG</creatorcontrib><creatorcontrib>NUSS, JOHN, M</creatorcontrib><creatorcontrib>LEW, AMY</creatorcontrib><creatorcontrib>BANNEN, LYNNE, CANNE</creatorcontrib><creatorcontrib>KLEIN, RHETT RONALD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHENG, WEI</au><au>LE, DONNA, T</au><au>PARKS, JASON JEVIOUS</au><au>WEN,, ZHAOYANG</au><au>MAC, MORRISON, B</au><au>BROWN, S., DAVID</au><au>KIM, MOON, HWAN</au><au>XU, WEI</au><au>CO, ERICK WANG</au><au>NUSS, JOHN, M</au><au>LEW, AMY</au><au>BANNEN, LYNNE, CANNE</au><au>KLEIN, RHETT RONALD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>KINASE MODULATORS</title><date>2009-07-29</date><risdate>2009</risdate><abstract>The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides oxindole derivatives which inhibit, regulate and/or modulate kinase receptor, particularly VEGF receptor 2 (Flk-1/KDR), FGFR1, and PDGFR (alpha and beta), signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP1581309A4 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | KINASE MODULATORS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T04%3A38%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHENG,%20WEI&rft.date=2009-07-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1581309A4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |